Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice

Epilepsy and Behavior

Volumn 18, Issue 3, 2010, Pages 207-210

  Bhutada, Pravinkumar ^a   Mundhada, Yogita ^a   Bansod, Kuldeep ^a   Dixit, Pankaj ^b   Umathe, Sudhir ^c   Mundhada, Dharmendra ^a  

^a Agnihotri College of Pharmacy Wardha   (India)

^b IPS Academy   (India)

^c RTM NAGPUR UNIVERSITY   (India)

Author keywords

Berberine; Convulsion; Epilepsy; MES induced seizures; NMDA; PTZ induced seizures

Indexed keywords

ANTICONVULSIVE AGENT; BERBERINE; DIAZEPAM; DIZOCILPINE; ISOQUINOLINE ALKALOID; KAINIC ACID; NEUROTRANSMITTER; PENTETRAZOLE; PHENYTOIN; N METHYLASPARTIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; MALE; MORTALITY; MOTOR COORDINATION; MOUSE; NONHUMAN; ROTAROD TEST; SEIZURE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG INTERACTION; ELECTROSHOCK; PATHOPHYSIOLOGY; PROCEDURES; SEIZURES;

ANIMALS; ANTICONVULSANTS; BERBERINE; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; KAINIC ACID; MALE; MICE; N-METHYLASPARTATE; PENTYLENETETRAZOLE; ROTAROD PERFORMANCE TEST; SEIZURES;

EID: 77954383420     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.03.007     Document Type: Article

References (35)

1. Nassiri-Asl M., Shariati-Rad S., Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med 2007, 7:26.
2. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
3. Carlini E.A. Plants and the central nervous system. Pharmacol Biochem Behav 2003, 3:501-512.
4. Quintans L.J., Silva D.A., Siqueira J.S., et al. Anticonvulsant properties of the total alkaloid fraction of Rauvolfia ligustrina Roem. et Schult. in male mice. Rev bras farmacogn 2007, 17:152-158.
5. Samren E.B., Van Duijn C.M., Koch S., et al. Maternal use of antiepileptic drugs and the risk of major congenital malfor malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997, 38:981-990.
6. Fatehi M., Saleh T.M., Fatehi-Hassanabad Z., Farrokhfal K., Jafarzadeh M., Davodi S.A. pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol 2005, 102:46-52.
7. Shanbhag S.M., Kulkarni H.J., Gaitonde B.B. Pharmacological actions of berberine on the central nervous system. Jap J Pharmac 1970, 20:482-487.
8. Schachter S.C. Botanicals and Herbs: A Traditional Approach to Treating Epilepsy. Neurotherapeutics 2009, 6:415-420.
9. Imanshahidi M., Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008, 22:999-1012.
10. Kupeli E., Kosar M., Yesilada E., Baser H.C. A comparative study on the anti-inflammatory, anti-nociceptive and anti-pyretic effects of isoquinolline alkaloids from the roots of Turkish Berberis species. Life Sci 2002, 72:645-657.
11. Peng W.H., Wu C.R., Chen C.S., Chen C.F., Leu Z.C., Hsieh M.T. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: Interaction with drugs acting at 5-HT receptors. Life Sci 2004, 75:2451-2462.
12. Wang F., Zhao G., Cheng L., Zhou H.Y., Fu L.Y., Yao W.X. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res 2004, 999:91-97.
13. Zhu F., Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 2006, 7:78-86.
14. Peng W.H., Lo K.L., Lee Y.H., Hung T.H., Lin Y.C. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci 2007, 81:933-938.
15. Kulkarni S.K., Dhir A. Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 2007, 569:77-83.
16. Kulkarni S.K., Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008, 589:163-172.
17. Kulkarni S.K., Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 2010, 24:317-324.
18. Yoo J.H., Yang E.M., Cho J.H., et al. Inhibitory effects of berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice. Neurosci 2006, 142:953-961.
19. Kong L.D., Cheng C.H., Tan R.X. Monoamine oxidase inhibitors from rhizome of Coptis chinensis. Planta Med 2001, 67:74-76.
20. Castillo J., Hung J., Rodriquez M., Bastidas E., Laboren I., Jaimes A. LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation. Anal Biochem 2005, 343:293-298.
21. Kohl B.K., Dannhardt G. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 2001, 8:1275-1289.
22. Wojtal K., Gniatkowska-Nowakowska A., Czuczwar S.J. Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs?. Pol J Pharmacol 2003, 55:535-542.
23. Bagdy G., Kecskemeti V., Riba P., Jakus R. Serotonin and epilepsy. J Neurochem. 2007, 100:857-873.
24. Nisar M., Khan I., Simjee S.U., Gilani A.H., Obaidullah, Perveen H. Anticonvulsant, analgesic and antipyretic activities of Taxus wallichiana Zucc. J Ethnopharmacol 2008, 116:490-494.
25. Swinyard E.A., Brown W.C., Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 1952, 106:319-330.
26. Rajput S.K., Krishnamoorthy S., Pawar C., et al. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog. Epilepsy Behav 2009, 14:48-53.
27. Ngo Bum E., Taiwe G.S., Nkainsa L.A., et al. Validation of anticonvulsant and sedative activity of six medicinal plants. Epilepsy Behav 2009, 14:454-458.
28. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1957, 46:208-209.
29. Rang H.P., Dale M.M., Ritter J.M., Moore P.K. Pharmacology 2007, 550-561. Churchill Livingstone, Edinburgh. fifth ed.
30. Cui H., Matsumoto K., Murakami Y., Hori H., Zhao Q., Obi R. Berberine Exerts Neuroprotective Actions against in Vitro Ischemia-Induced Neuronal Cell Damage in Organotypic Hippocampal Slice Cultures: Involvement of B-Cell Lymphoma 2 Phosphorylation Suppression. Biol Pharm Bull 2009, 32:79-85.
31. Czuczwar S.J., Turski L., Schwarz M., Turski W.A., Kleinrok Z. Effects of excitatory amino-acid antagonists on the anticonvulsive action of phenobarbital or diphenylhydantoin in mice. Eur J Pharmacol 1984, 100:357-362.
32. Czuczwar M., Ciêszczyk J., Czuczwar K., Kioe J., Saran T., Turski W.A. Influence of orphenadrine upon the protective activity of various antiepileptics in the maximal electroshock-induced convulsions in mice. Pharmacol Reports 2009, 61:732-736.
33. Katzung B.G. Basic and Clinical Pharmacology 2004, 379-399. McGraw-Hill Inc, Boston, London, Toronto. ninth ed.
34. Schachter S.C. Epilepsy: major advances in treatment. Lancet Neurol 2004, 3:11.
35. Hermann B., Meador K.J., Gaillard W.D., Cramer J.A. Cognition across the lifespan: Antiepileptic drugs, epilepsy, or both?. Epilepsy Behav 2010, 17:1-5.